In this context, it will be important to clarify whether early ART treatment initiation, when CD4 T-cell counts are still high, may counteract HIV-induced T-cell dysfunction, reduce risk for HPV virus persistence thereby reducing the risk of cervical cancer. This evidence concerns the gene CD4 and cervical carcinoma.